Diagnostics Dialogues
Trends in drug testing resulting from the COVID-19 pandemic

Trends in drug testing resulting from the COVID-19 pandemic

August 25, 2021

Trends in drug testing resulting form the COVID-19 pandemic

The convergence of the opioid epidemic and the coronavirus disease 2019 (COVID-19) pandemic has created new healthcare challenges. Health systems, from a system- and individual clinician-level, are more important than ever in the pursuit of addressing the epidemic within the pandemic.

In this session, Dr Gudin discusses:

  • Recently-published data by Quest that demonstrates decreased drug testing overall, with increased positivity for high-risk drugs and dangerous drug combinations 
  • Tools and practices for clinicians to assess and stratify patients for potential prescription drug abuse
  • System-level strategies that employ an integrated care delivery approach, including leveraging community and diagnostics partnerships, to support impacted patient populations

Jeffrey Gudin, MD; Executive Director, Medical Affairs, Drug Monitoring & Toxicology

Dr Gudin is an active speaker and advisor whose clinical and research interests include postoperative pain management; opioid abuse, and potential solutions; and increasing clinical awareness of pain assessment and risk management. Board-certified in pain management, addiction medicine, and hospice and palliative medicine, Dr Gudin is also a medical acupuncturist. He serves as co-Editor-at-Large for Practical Pain Management.

Read the rest of this entry »

Patient-minded Neurology

Patient-minded Neurology

June 11, 2021


This episode features Dr Michael Racke discussing the evolution of treating neurologic disease to detect disease early and focus on prevention.  In this session, Dr Racke discusses:

  • How diagnostics and treatment has evolved for multiple sclerosis
  • Treating patients at the first incidence of neurologic disease for optimal outcomes
  • How health systems can address the needs of patients with complex neurologic conditions to minimize the human and economic toll of disease

Michael Racke MD Bio:


Dr Michael K. Racke is Medical Director for Neurology at Quest Diagnostics. Dr Racke is a leader in the field of neurology and neuroimmunology. Dr Racke is the author of more than 200 peer-reviewed papers, book chapters, and reviews spanning the pathogenesis of neuroimmunologic diseases. He continues to serve on several national professional society committees.

Read the rest of this entry »

Optimize Oncology Care with Clinical Pathways

Optimize Oncology Care with Clinical Pathways

May 12, 2021

Dr Yuri Fesko Optimizing Oncology Care with Quest's Clinical Pathways


This episode features Yuri Fesko MD, with clinical pathways to help guide diagnosis and treatment in oncology. In this session, Dr Fesko discusses:

  • How clinical pathways can make an impact for hospitals to improve oncology outcomes
  • The critical importance of collaboration for pathologists and oncologists
  • The future of oncology care in integrated health systems

Yuri Fesko MD Bio:

Dr Yuri Fesko serves as the Executive Medical Director of Medical Affairs at Quest Diagnostics, and the Chief Clinical Officer for Oncology Strategic Collaboration at Quest. Born and raised in New York City, Dr Fesko trained at Case Western Reserve University, and completed his fellowship at University Hospitals of Cleveland. After his fellowship, Dr Fesko served as the Chief of Community Oncology for Wake County through Duke University Health System.An experienced oncologist and medical business leader, he is currently responsible for strategic clinical development at Quest across multiple functional areas including Regulatory FDA, HEOR, and R&D.

Read the rest of this entry »

COVID-19: Supporting Safety for the Front Line

COVID-19: Supporting Safety for the Front Line

April 7, 2021

Quest Diagnostics Dialogues

Today’s podcast features Dr Nicholaos Bellos with strategies that are helping some health systems best operate in today's healthcare environment. In this session, Dr Bellos discusses:

  • The ease of viral transmission and what health systems can do to mitigate risk
  • Diagnostic solutions, guidelines, and best practices to ensure safety for the front line
  • The future of health systems in the post-pandemic landscape

Nicholaos Bellos MD Bio:

Board-certified in internal medicine and infectious disease, Dr Nicholaos Bellos brings both deep clinical knowledge and executive leadership experience to the discussion. Drawing from his passion for advancing positive outcomes for patients, his expertise includes delivering evidence-based, measurable healthcare solutions that contain costs, reduce hospital length-of-stay and readmissions, and cut down on hospital-acquired drug-resistant infections. Dr Bellos maintains a private clinical practice of over 20 years, as well as serving as national medical director, extended care services at Quest Diagnostics. Previously, he was associate vice president of medical operations and performance management and innovation at Tenet Health.

Read the rest of this entry »

About Diagnostics Dialogues from Quest Diagnostics

About Diagnostics Dialogues from Quest Diagnostics

April 5, 2021


When we asked Dr. Alagia his goals for this podcast, he told us, "I think the podcast project gives our doctors and our scientists at Quest a voice. It connects us with the outside community. We work with a lot of folks who live in the laboratories, who live in the hospitals, who do great work here. It's essential work. Everything starts with the lab. We can't treat a patient without laboratorians and all the work that they do. We wanted to make sure that people understood how number one, important they are, but how powerful their intellects are in terms of contributing to patient care. Without them, everything stops." 

He then added, "One of the things that's important for us to talk about is care, science, and community. When people hear that it's not just the testing and the analytics and everything else that we do and the insights that we provide, but really at the core of everything we do is patient care, and that's what our north star is. That's what drives us."

We are glad to welcome you to Diagnostics Dialogues from Quest Diagnostics. Be sure to subcribe.



Podbean App

Play this podcast on Podbean App